Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas
β Scribed by P. Beauchesne; C. Soler; P. Rusch; M. J. Fotso; R. Duthel; T. Schmitt; J. Brunon
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 99 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Diffuse pontine gliomas remain one of the most lethal of pediatric malignancies despite the use of increasingly intensive therapies. we delivered intensive chemotherapy during and following 70.2 gy of hyperfractionated radiation therapy in an attempt to improve survival. ## Procedur
## BACKGROUND. Brainstem gliomas often respond to radiotherapy but long term disease control is exceptional. The concomitant administration of a chemotherapy agent with radiosensitizing properties such as carboplatin may increase the efficacy of radiotherapy.
## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients